Karla Adams, Matthew Greenhawt, Theresa Bingemann, James Tracy, Joel Brooks, Hans Otto, Daniel Steigelman, Yvonne Hsieh, Aikaterini Anagnostou, John Carlson, Jeffrey Demain, Aasha Harish, Nina Hein, Anil Nanda, Monica Hajirawala, Susan Waserman, David B K Golden
{"title":"Insect Allergy: Barriers in Training and Practice: A Work Group Report of the AAAAI Anaphylaxis Committee.","authors":"Karla Adams, Matthew Greenhawt, Theresa Bingemann, James Tracy, Joel Brooks, Hans Otto, Daniel Steigelman, Yvonne Hsieh, Aikaterini Anagnostou, John Carlson, Jeffrey Demain, Aasha Harish, Nina Hein, Anil Nanda, Monica Hajirawala, Susan Waserman, David B K Golden","doi":"10.1016/j.jaip.2024.12.037","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The evaluation and management of insect sting allergy is a complex core competency taught in Allergy and Immunology fellowship programs. It is unclear if current training on insect allergy is sufficient to meet the needs of the field, and what training barriers exist.</p><p><strong>Objective: </strong>To investigate the extent of training on stinging insect allergy, and factors currently impacting stinging insect allergy clinical practice through a pilot needs-assessment survey.</p><p><strong>Methods: </strong>A web-based questionnaire was designed and sent to a 20% random sample of American Academy of Allergy, Asthma & Immunology member categories. Data were analyzed for descriptive frequencies.</p><p><strong>Results: </strong>A total of 78 responses were received (11% response rate). Respondents' mean age was 53.7 years, 52% were female and 92.3% were physicians. The mean time since training completion was 18.4 years. During fellowship training, 95.7% were educated on stinging insect allergy, 87.1% reported conducting testing and 82.6% ordered venom immunotherapy (VIT). During training, 50% of respondents managed 1-5 patients with venom allergy, (38% managed >5, and 12% none). After fellowship, 97.3% reported evaluating patients with stinging insect allergy, 90.3% report evaluating 1-5 patients per month and 93.2% and 87.5% offer testing and VIT (respectively). A patient's decision to not start VIT was the most common barrier reported by 81.8%.</p><p><strong>Conclusion: </strong>In this pilot needs-assessment survey, the majority reported training and education on insect allergy during fellowship, though patient exposure was low for most. After fellowship, insect allergy evaluations increase up to 24-fold compared to fellowship training and patient-driven decisions are the most common deterrent for VIT.</p>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaip.2024.12.037","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The evaluation and management of insect sting allergy is a complex core competency taught in Allergy and Immunology fellowship programs. It is unclear if current training on insect allergy is sufficient to meet the needs of the field, and what training barriers exist.
Objective: To investigate the extent of training on stinging insect allergy, and factors currently impacting stinging insect allergy clinical practice through a pilot needs-assessment survey.
Methods: A web-based questionnaire was designed and sent to a 20% random sample of American Academy of Allergy, Asthma & Immunology member categories. Data were analyzed for descriptive frequencies.
Results: A total of 78 responses were received (11% response rate). Respondents' mean age was 53.7 years, 52% were female and 92.3% were physicians. The mean time since training completion was 18.4 years. During fellowship training, 95.7% were educated on stinging insect allergy, 87.1% reported conducting testing and 82.6% ordered venom immunotherapy (VIT). During training, 50% of respondents managed 1-5 patients with venom allergy, (38% managed >5, and 12% none). After fellowship, 97.3% reported evaluating patients with stinging insect allergy, 90.3% report evaluating 1-5 patients per month and 93.2% and 87.5% offer testing and VIT (respectively). A patient's decision to not start VIT was the most common barrier reported by 81.8%.
Conclusion: In this pilot needs-assessment survey, the majority reported training and education on insect allergy during fellowship, though patient exposure was low for most. After fellowship, insect allergy evaluations increase up to 24-fold compared to fellowship training and patient-driven decisions are the most common deterrent for VIT.
期刊介绍:
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases.
This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders.
The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.